Table I.
|
CD4+CD25hi T cells from: a
|
|||||
---|---|---|---|---|---|---|
Chronically infected mice | Naive mice | |||||
Number of cell divisions | BMDCs | Infected BMDCs | LPS-treated BMDCs | Anti-CD40 and LPS-treated BMDCs | BMDCs | Infected BMDCs |
0 | 93.2 | 32.9 | 82.1 | 86.3 | 74.7 | 68.5 |
1 | 4.4 | 33.7 | 15.5 | 7.4 | 18.9 | 19.5 |
2 | 1.2 | 14.3 | 2.2 | 3.8 | 4.5 | 6.6 |
3 | 1.2 | 15.3 | 0.2 | 1.6 | 1.1 | 3.4 |
4 | 0.0 | 3.8 | 0.0 | 0.9 | 0.9 | 1.9 |
Data are representative of at least two independent experiments.
CD4+CD25hi T cells were sorted from the draining LNs of B/6 mice infected in the ear dermis with 103 L. major metacyclic promastigotes for 5 mo or from the same LNs of naive mice. 5 × 104 CFSE-labeled CD4+CD25+ T cells and 5 × 105 BMDCs were cultured for 3 d. BMDCs were either untreated or previously incubated overnight with L. major metacyclic promastigotes or stimulated with 50 ng/ml LPS (alone or with 1 μg/ml anti-CD40). Cells were analyzed by flow cytometry, and cell divisions were analyzed on the gated CD4+TCR-β+ cells with ModFit software.